PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Samsara Inc. (IOT)
33.600.80 (-2.33%)
33.44 - 34.57
31.40 - 61.90
7.61M / 5.87M (Avg.)
-152.73 | -0.22
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-97.47%
Both yoy net incomes decline, with BRZE at -107.31%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
7.04%
Some D&A expansion while BRZE is negative at -5.13%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
No Data
No Data available this quarter, please select a different quarter.
11.68%
SBC growth well above BRZE's 9.61%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-36.75%
Negative yoy working capital usage while BRZE is 368.03%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
130.38%
AR growth is negative or stable vs. BRZE's 277.34%, indicating tighter credit discipline. David Dodd would confirm it doesn't hamper sales volume.
149.84%
Inventory growth of 149.84% while BRZE is zero at 0.00%. Bruce Berkowitz would see a moderate build that must match future sales to avoid risk.
-161.16%
Both negative yoy AP, with BRZE at -66.89%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
5685.63%
Growth well above BRZE's 3585.27%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
46.02%
Well above BRZE's 11.36%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-2.32%
Negative yoy CFO while BRZE is 41.33%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-29.42%
Negative yoy CapEx while BRZE is 80.04%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
-40.32%
Both yoy lines negative, with BRZE at -36.26%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
25.34%
Below 50% of BRZE's 386.59%. Michael Burry would see minimal near-term inflows vs. competitor’s liquidation approach.
No Data
No Data available this quarter, please select a different quarter.
-3894.40%
We reduce yoy invests while BRZE stands at 14706.06%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
-7.69%
We cut debt repayment yoy while BRZE is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.